mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.062 |
0.7 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.06 |
0.7 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.062 |
0.7 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.7 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |